The FDA issued a consumer alert against Matrixx Initiatives' Zicam cold treatments after receiving 130 reports of people losing their sense of smell after using the nasal therapies. Matrixx said that the FDA's warning is "unwarranted" and that it intends to discuss its product-safety data with the agency.

Full Story:

Related Summaries